Estrogen-induced regulation of the ATP-binding cassette transporter A1 (ABCA1) in mice: A possible mechanism of atheroprotection by estrogen

被引:30
作者
Srivastava, RAK [1 ]
机构
[1] CloneGen Biotechnol, Ann Arbor, MI 48105 USA
关键词
estrogen; ABCA1; atherosclerosis; apoA1 transgenic mice; high fat;
D O I
10.1023/A:1020604610873
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Estrogens are suggested to be antiatherogenic by affecting the vessel wall components. Since ABCA1 was recently shown to be atheroprotective, it was examined if estrogen-induced atheroprotection occurs partly via the regulation of the ABCA1. Since hepatic ABCA1 expression was also suggested to contribute to the bulk HDL levels, regulation of the ABCA1 under conditions of high or low levels of HDL were investigated in mice expressing normal or elevated levels of apoAI. To delineate whether estrogen's effect occurs via estrogen receptor-alpha-mediated pathway, the estrogen receptor-alpha-deficient (ER-alpha)(-/-) mice were also administered either placebo or beta-estradiol for 5 consecutive days. Estrogen treatments decreased circulating HDL levels by 30%, but increased hepatic and intestinal ABCA1 mRNA by 2- and 1.5- fold, respectively. Hepatic ABCA1 mRNA also increased in the ER-/- mice by 3-fold. These results suggest that estrogen, despite lowering the levels of HDL, it up-regulated the hepatic ABCA1 mRNA, and in the absence of ER-alpha, ER-beta could compensate for ER-alpha. To study whether HDL levels correlate with the ABCA1 expression, wild-type (WT) and the apoAI transgenic (A1-Tg) mice were fed high fat (HF) diet with or without cholic acid (CA) for 3 weeks. One group of mice was treated with fenofibrate, known to elevate HDL levels. CA without HF decreased HDL levels, while fenofibrate increased HDL levels. However, neither CA nor fenofibrate altered hepatic ABCA1 mRNA levels. HF diet increased the hepatic ABCA1 mRNA 1.8-fold in WT, but lowered ABCA1 mRNA by 2-fold in A1-Tg mice, suggesting that ABCA1 levels did not correlate with circulating HDL levels, while basal levels of HDL influenced ABCA1 expression. These data show for the first time that estrogen's antiatherogenic effects may occur via ABCA1-mediated pathway, and circulating HDL levels may influence expression of ABCA1.
引用
收藏
页码:67 / 73
页数:7
相关论文
共 36 条
  • [1] IN-VIVO REGULATION OF LOW-DENSITY-LIPOPROTEIN RECEPTORS BY ESTROGEN DIFFERS AT THE POSTTRANSCRIPTIONAL LEVEL IN RAT AND MOUSE
    AJIT, R
    SRIVASTAVA, K
    BAUMANN, D
    SCHONFELD, G
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 216 (02): : 527 - 538
  • [2] Expression of human apolipoprotein A-I/C-III/A-IV gene cluster in mice reduces atherogenesis in response to a high fat-high cholesterol diet
    Baroukh, N
    Ostos, MA
    Vergnes, L
    Recalde, D
    Staels, B
    Fruchart, JC
    Ochoa, A
    Castro, G
    Zakin, MM
    [J]. FEBS LETTERS, 2001, 502 (1-2) : 16 - 20
  • [3] The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
    Bodzioch, M
    Orsó, E
    Klucken, T
    Langmann, T
    Böttcher, L
    Diederich, W
    Drobnik, W
    Barlage, S
    Büchler, C
    Porsch-Özcürümez, M
    Kaminski, WE
    Hahmann, HW
    Oette, K
    Rothe, G
    Aslanidis, C
    Lackner, KJ
    Schmitz, G
    [J]. NATURE GENETICS, 1999, 22 (04) : 347 - 351
  • [4] Induction of the phospholipid transfer protein gene accounts for the high density lipoprotein enlargement in mice treated with fenofibrate
    Bouly, M
    Masson, D
    Gross, B
    Jiang, XC
    Fievet, C
    Castro, G
    Tall, AR
    Fruchart, JC
    Staels, B
    Lagrost, L
    Luc, G
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (28) : 25841 - 25847
  • [5] Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
    Brooks-Wilson, A
    Marcil, M
    Clee, SM
    Zhang, LH
    Roomp, K
    van Dam, M
    Yu, L
    Brewer, C
    Collins, JA
    Molhuizen, HOF
    Loubser, O
    Ouelette, BFF
    Fichter, K
    Ashbourne-Excoffon, KJD
    Sensen, CW
    Scherer, S
    Mott, S
    Denis, M
    Martindale, D
    Frohlich, J
    Morgan, K
    Koop, B
    Pimstone, S
    Kastelein, JJP
    Genest, J
    Hayden, MR
    [J]. NATURE GENETICS, 1999, 22 (04) : 336 - 345
  • [6] Regulation and activity of the human ABCA1 gene in transgenic mice
    Cavelier, LB
    Qiu, Y
    Bielicki, JK
    Afzal, V
    Cheng, JF
    Rubin, EM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (21) : 18046 - 18051
  • [7] PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway
    Chinetti, G
    Lestavel, S
    Bocher, V
    Remaley, AT
    Neve, B
    Torra, IP
    Teissier, E
    Minnich, A
    Jaye, M
    Duverger, N
    Brewer, HB
    Fruchart, JC
    Clavey, V
    Staels, B
    [J]. NATURE MEDICINE, 2001, 7 (01) : 53 - 58
  • [8] Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes
    Clee, SM
    Kastelein, JJP
    van Dam, M
    Marcil, M
    Roomp, K
    Zwarts, KY
    Collins, JA
    Roelants, R
    Tamasawa, N
    Stulc, T
    Suda, T
    Ceska, R
    Boucher, B
    Rondeau, C
    DeSouich, C
    Brooks-Wilson, A
    Molhuizen, HOF
    Frohlich, J
    Genest, J
    Hayden, MR
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (10) : 1263 - 1270
  • [9] Costet P, 2000, J BIOL CHEM, V275, P28240
  • [10] ECK MV, 2001, SCI SESS AM HEART AS